Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ultragenyx Pharmaceutical

33.51
-1.5500-4.42%
Volume:962.21K
Turnover:32.46M
Market Cap:3.14B
PE:-5.33
High:36.03
Open:35.66
Low:32.78
Close:35.06
Loading ...

Analysts Have Conflicting Sentiments on These Healthcare Companies: Ultragenyx Pharmaceutical (RARE), Bicycle Therapeutics (BCYC) and Quest Diagnostics (DGX)

TIPRANKS
·
16 Dec 2024

Analysts Offer Insights on Healthcare Companies: Evolus (EOLS), Ultragenyx Pharmaceutical (RARE) and Henry Schein (HSIC)

TIPRANKS
·
16 Dec 2024

TD Cowen Keeps Their Buy Rating on Ultragenyx Pharmaceutical (RARE)

TIPRANKS
·
11 Dec 2024

Ultragenyx (RARE) Down 6.8% Since Last Earnings Report: Can It Rebound?

Zacks
·
06 Dec 2024

Possible Bearish Signals With Ultragenyx Pharmaceutical Insiders Disposing Stock

Simply Wall St.
·
04 Dec 2024

HARMONY BIOSCIENCES TO PARTICIPATE IN OPPENHEIMER MOVERS IN RARE DISEASE SUMMIT

PR Newswire
·
03 Dec 2024

Ultragenyx to Participate in Investor Conferences in December

GlobeNewswire
·
27 Nov 2024

Ultragenyx Pharma Is Maintained at Overweight by JP Morgan

Dow Jones
·
21 Nov 2024

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
21 Nov 2024

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
21 Nov 2024

AMGEN PRESENTS NEW DATA ACROSS RARE INFLAMMATORY DISEASES AT ACR 2024

PR Newswire
·
15 Nov 2024

Strong Buy Rating for Ultragenyx Pharmaceutical: Promising Phase 3 Prospects and Market Confidence

TIPRANKS
·
12 Nov 2024

Stock Track | Ultragenyx Pharmaceutical Stock Soars on Analyst's Bullish Report

Stock Track
·
11 Nov 2024

Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE) and Opus Genetics (IRD)

TIPRANKS
·
11 Nov 2024

TD Cowen Remains a Buy on Ultragenyx Pharmaceutical (RARE)

TIPRANKS
·
11 Nov 2024

Watch Out: A Huge Number of Altcoins Will Have Massive Token Unlocks in the New Week – Here’s a Day-by-Day, Hour-by-Hour List

CoinMarketCap
·
11 Nov 2024

Ultragenyx posts trial data backing Phase 3 design for Angelman syndrome therapy

seekingalpha
·
10 Nov 2024

Ultragenyx Presents Positive Update on Gtx-102 Angelman Syndrome Program at Fast’s 17TH Annual Global Science Summit

THOMSON REUTERS
·
09 Nov 2024

Ultragenyx Presents Positive Update on GTX-102 Angelman Syndrome Program at FAST’s 17th Annual Global Science Summit

GlobeNewswire
·
09 Nov 2024